Abstract

Inflammation is a live tissue's immunological reaction to an allergen or injury to a bodily component. The majority of anti-inflammatory medicines are synthetic, and long-term usage of these medications can have serious side effects and harm the human biological system. Medicago laciniata, sometimes known as cutleaf medick traditionally used as an abortifacient, anti-inflammatory, antidepressant, and antidiabetic. The goal of this study was to scientifically document the anti-inflammatory activity of the aerial portions of Medicago laciniata. For this purpose, extraction was carried out using solvents ethyl acetate and n-hexane. The preliminary phytochemical screening was performed to check the presence of important secondary metabolites followed by applying the carrageenan-induced edema hind paw method to test the anti-inflammatory efficacy of both extracts. The result showed the presence of secondary flavonoids steroids, terpenoids, saponins, and tannins. In vivo anti-inflammatory activity showed that after five hours, the maximum reduction of 70.90% and 69.29% were observed for ethyl acetate and n-hexane extracts respectively, each at a dose of 100 mg/kg, respectively. This study suggests that Medicago laciniata has an excellent ability to protect against inflammation due to the presence of secondary metabolites.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call